Bioqual (OTCMKTS:BIOQ) Shares Down 0.5% – What’s Next?

Shares of Bioqual Inc. (OTCMKTS:BIOQ) traded down 0.5% on Monday . The stock traded as low as $35.01 and last traded at $35.01. 200 shares were traded during trading, an increase of 3,233% from the average session volume of 6 shares. The stock had previously closed at $35.20.

Bioqual Price Performance

The company has a market capitalization of $31.16 million, a price-to-earnings ratio of -32.42 and a beta of -0.17. The firm has a 50-day moving average price of $37.14 and a two-hundred day moving average price of $37.94.

Bioqual (OTCMKTS:BIOQ) last posted its quarterly earnings data on Tuesday, April 21st. The company reported ($0.84) earnings per share for the quarter. The firm had revenue of $9.84 million for the quarter. Bioqual had a negative return on equity of 2.67% and a negative net margin of 2.27%.

Bioqual Company Profile

Bioqual, Inc is a U.S.-based contract research organization specializing in preclinical immunology and pharmacology services for the biopharmaceutical industry. The company offers a range of in vivo and in vitro testing solutions designed to support vaccine development, immuno-oncology programs and other therapeutic modalities. Bioqual’s service portfolio encompasses assay development, safety and efficacy studies, biomarker analysis and specialized immunogenicity assessments.

Leveraging proprietary humanized animal models and nonhuman primate research platforms, Bioqual helps clients evaluate biological activity, toxicity and pharmacokinetics of investigational compounds.